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Wastewater analysis and drugs: 
a European multi-city study
Wastewater analysis is a rapidly developing scientific 
discipline with the potential for monitoring real-time data on 
geographical and temporal trends in illicit drug use. Originally 
used in the 1990s to monitor the environmental impact of 
liquid household waste, the method has since been used to 
estimate illicit drug consumption in different cities (Daughton, 
2001; Zuccato et al., 2008; van Nuijs et al., 2011). It involves 
sampling a source of wastewater, such as a sewage influent 
to a wastewater treatment plant. This allows scientists to 
estimate the quantity of drugs consumed by a community 
by measuring the levels of illicit drugs and their metabolites 
excreted in urine (Zuccato et al., 2008).
I  Wastewater testing in European cities
In 2010 a Europe-wide network (Sewage analysis CORe 
group — Europe (SCORE)) was established with the aim 
of standardising the approaches used for wastewater 
analysis and coordinating international studies through the 
establishment of a common protocol of action (1). The first 
activity of the SCORE group was a Europe-wide investigation, 
performed in 2011 in 19 European cities, which allowed the 
first ever wastewater study of regional differences in illicit drug 
use in Europe (Thomas et al., 2012). That study also included 
the first intercalibration exercise for the evaluation of the 
quality of the analytical data and allowed a comprehensive 
characterisation of the major uncertainties of the approach 
(Castiglioni et al., 2014). Following the success of this initial 
study, comparable studies were undertaken over the following 
four years, covering 56 cities and 19 countries in Europe in 
2017. A standard protocol and a common quality control 
exercise were used in all locations, which made it possible 
(1) The protocol can be found on the EMCDDA website: www.emcdda.europa.eu/
wastewater-analysis
The findings of the largest European 
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of wastewater analysis are taken up in 
this ‘Perspective on drugs’. The project in 
question analysed wastewater in around 
60 European cities and towns (hereinafter 
referred to as ‘cities’) to explore the drug-
taking habits of those who live in them. 
The results provide a valuable snapshot of 
the drug flow through the cities involved, 
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to directly compare illicit drug loads in Europe over a one-
week period during seven consecutive years. For the 2017 
wastewater monitoring campaign, raw 24-hour composite 
samples were collected during a single week in March. 
These samples were analysed for the urinary biomarkers 
(i.e. measurable characteristics) of the parent drug (i.e. 
primary substance) for amphetamine, methamphetamine 
and MDMA. In addition, the samples were analysed for the 
main urinary metabolites (i.e. substances produced when the 
body breaks drugs down) of cocaine and cannabis, which are 
benzoylecgonine (BE) and THC-COOH (11-nor-9-carboxy-
delta9-tetrahydrocannabinol). 
This report is focused on illicit stimulants. No results for 
cannabis are reported, as THC-COOH presents wastewater 
epidemiology with a number of technical challenges, which 
are the subject of ongoing research (Causanilles et al., 2017a).
I  Patterns of illicit drug use: geographical and temporal variation 
2017 key findings 
The project revealed a picture of distinct geographical and 
temporal patterns of drug use across European cities (see 
Interactive: explore the data from the study).
The BE loads observed in wastewater indicate that cocaine 
use is highest in western and southern European cities, in 
particular in cities in Belgium, the Netherlands, Spain and 
the United Kingdom. Wastewater analysis indicates that 
cocaine use is very low to negligible in the majority of eastern 
European cities.
The loads of amphetamine detected in wastewater varied 
considerably across study locations, with the highest 
levels reported in cities in the north and east of Europe. 
Amphetamine was found at much lower levels in cities in the 
south of Europe.
In contrast, methamphetamine use, generally low and 
historically concentrated in the Czech Republic and 
Slovakia, now appears to be present also in Cyprus, the 
east of Germany and northern Europe. The observed 
methamphetamine loads in the other locations were very low 
to negligible. 
The highest mass loads of MDMA were found in the 
wastewater in cities in Belgium, Germany and the 
Netherlands. 
Ten countries participating in the 2017 monitoring campaign 
included two or more study locations (Belgium, Cyprus, Czech 
Republic, Germany, Finland, France, Netherlands, Portugal, 
Spain and Slovakia). The study highlighted differences 
between these cities within the same country, which may 
be explained in part by the different social and demographic 
characteristics of the cities (universities, nightlife areas and 
age distribution of the population). In the large majority 
of countries with multiple study locations, cocaine and 
MDMA loads were higher in large cities compared to 
smaller locations. No such differences could be detected for 
amphetamine and methamphetamine.
In addition to geographical patterns, wastewater analysis can 
detect fluctuations in weekly patterns of illicit drug use. More 
than three-quarters of cities show higher loads of BE and 
MDMA in wastewater during the weekend (Friday to Monday) 
than during weekdays. In contrast, amphetamine use was 
found to be distributed more evenly over the whole week.
Trend data
Twenty-one cities have participated in at least five of the 
annual wastewater monitoring campaigns since 2011, which 
allows for time trend analysis of drug consumption based on 
wastewater testing.
A relatively stable picture of cocaine use was observed 
between 2011 and 2015 in most cities.. The general patterns 
detected were similar in the first five consecutive monitoring 
campaigns, with the highest and lowest BE loads found in the 
same cities and regions. Most cities show either a decreasing 
or a stable trend between 2011 and 2015. In 2016, there 
were initial signs that this pattern was changing with 22 
out of 33 cities with data for 2015 and 2016 reporting an 
increase. This was confirmed in 2017, with 19 out of the 31 
cities with data for 2016 and 2017 reporting an increase in 
the loads found. Most of the 13 cities with data for 2011 and 
2017 report increasing longer-term trends.
Over the seven years of monitoring the highest MDMA loads 
were consistently found in the wastewater of cities in Belgium 
and the Netherlands. Looking at longer term trends, in most 
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cities with at least six data points wastewater MDMA loads 
were higher in 2017 than in 2011, with sharp increases 
observed in some cities, including Antwerp and Amsterdam. 
For most of those cities that observed sharp increases for the 
period 2011–16, the trend seems to have stabilised in 2017.
Overall, the data related to amphetamine and 
methamphetamine from the seven monitoring campaigns 
showed no major changes in the general patterns of use 
observed.
I  Comparison with findings from other monitoring tools
Because different types of information are provided by 
wastewater analysis (collective consumption of substances 
within a community) and by established monitoring tools, 
such as population surveys (prevalence in the last month or 
year), a direct comparison of the data is difficult. However, the 
patterns and trends being detected by wastewater analysis 
are largely, but not completely, in line with the analyses 
coming from other monitoring tools.
For example, both seizure and wastewater data present a 
picture of a geographically divergent stimulant market in 
Europe, where cocaine is more prevalent in the south and 
west, while amphetamines are more common in central and 
northern countries (EMCDDA, 2017). Similar results are also 
found in data coming from population surveys on drug use. 
While the general pattern detected in wastewater is in line 
with established monitoring tools, there are some exceptions: 
the amphetamine loads in wastewater in Paris have been 
below the level of quantification over the consecutive annual 
monitoring campaigns, contrary to indications from other 
monitoring tools.
Data from established indicators show that 
methamphetamine use has historically been restricted to the 
Czech Republic, and more recently also Slovakia, although 
recent years have seen increased use in other countries 
(EMCDDA, 2016a). These findings have been confirmed by 
recent wastewater-based epidemiology, with the highest 
methamphetamine loads found in Czech, Slovak, German 
and Finnish cities.
Established indicators show that, until recently, MDMA 
prevalence was declining in many countries from peak levels 
in the early to mid 2000s. Data from wastewater and from 
established indicators show that this appears to be changing, 
with the large majority of cities reporting higher wastewater 
MDMA loads in 2016 or 2017 than in 2011. 
Similarly, studies based on self-reported drug use and those 
using wastewater data both point towards the same weekly 
variations in use, with stimulants such as amphetamine and 
cocaine being primarily used at weekend music events and in 
celebratory contexts (Tossmann et al., 2001).
A limited but steadily increasing number of studies have 
been published comparing drug use estimates obtained 
through wastewater analysis and estimates provided by 
epidemiological surveys (EMCDDA, 2016b; van Wel et al., 
2015). While in 2012 only one reported study tried to evaluate 
sewage analysis alongside traditional epidemiological 
techniques (Reid et al., 2012), this number has now 
increased to around 20 published research articles that are 
focused on comparing information provided by wastewater 
analysis and information provided by other indicators.
A first study, performed in Oslo, Norway, and published in 
2012, compared the results from three different datasets  
(a general population survey, a roadside survey and 
wastewater analysis) (Reid et al., 2012). 
I  Terms and definitions 
Back-calculation is the process whereby researchers 
calculate/estimate the consumption of illicit drugs in 
the population based on the amounts of the target drug 
residue entering the wastewater treatment plant.
Liquid chromatography–tandem mass spectrometry 
(LC-MS/MS) is the analytical method most commonly 
used to quantify drug residues in wastewater. LC-MS/MS 
is an analytical chemistry technique that combines the 
separation techniques of liquid chromatography with the 
analysis capabilities of mass spectrometry. Considering 
the complexity and the low concentrations expected 
in wastewater, LC-MS/MS is one of the most powerful 
techniques for this analysis, because of its sensitivity and 
selectivity.
Metabolite  Traces of drugs consumed will end up in 
the sewer network either unchanged or as a mixture of 
metabolites. Metabolites, the end products of metabolism, 
are the substances produced when the body breaks drugs 
down. 
Residue  Wastewater analysis is based on the fact that 
we excrete traces in our urine of almost everything we 
consume, including illicit drugs. The target drug residue 
is what remains in the wastewater after excretion and is 
used to quantify the consumption of illicit drugs in the 
population.
Urinary biomarkers  Analytical chemists look for urinary 
biomarkers (measurable characteristics to calculate 
population drug use) in wastewater samples, which can be 
the parent drug (i.e. the primary substance) or its urinary 
metabolites.
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Other, more recent studies compare and correlate 
wastewater-based consumption estimates of illicit drugs 
with other data sources, including self-reported data (Been 
et al., 2015; Castiglioni et al., 2016; van Wel et al., 2016a), 
consumption offences (Been et al., 2016a), illicit drug 
seizures (Baz-Lomba et al., 2016; Kankaanpää et al., 2014, 
2016), syringe distribution estimates (Been et al., 2015) 
toxicological data (Kankaanpää et al., 2014, 2016) and the 
number of drug users in treatment (Krizman et al., 2016).  
The majority of comparative studies have been carried out 
within Europe, including in Belgium (van Wel et al., 2016a), 
Croatia (Krizman et al., 2016), Germany (Been et al., 2016a), 
Finland (Kankaanpää et al., 2014, 2016), Italy (Castiglioni et 
al., 2016), Switzerland (Been et al., 2015; Been et al., 2016b) 
and across European countries (Baz-Lomba et al., 2016, 
Castrignanò et al., 2018, Löve et al., 2018). Outside Europe, 
in recent years studies have been published comparing 
wastewater-based estimates with other data sources in 
China (Du et al., 2015), Australia (Tscharke et al., 2015) and 
in countries where data on drug use is limited due to financial 
constraints or lack of monitoring tools (Archer et al., 2018). 
These examples confirm the promising future of wastewater-
based epidemiology as a complementary approach to 
obtain a more accurate and balanced picture of substance 
use within different communities. Wastewater analysis can 
predict results from population surveys and can be used as 
a ‘first alert’ tool in the identification of new trends in drug 
consumption.
I  Limitations of this method
Wastewater analysis offers an interesting complementary 
data source for monitoring the quantities of illicit drugs used 
at the population level, but it cannot provide information 
on prevalence and frequency of use, main classes of users 
and purity of the drugs. Additional challenges arise from 
uncertainties associated with the behaviour of the selected 
biomarkers in the sewer, different back-calculation methods 
and different approaches to estimate the size of the 
population being tested (Castiglioni et al., 2013, 2016; Lai 
et al., 2014; EMCDDA, 2016b). The caveats in selecting the 
analytical targets for heroin, for example, make monitoring 
this drug in wastewater more complicated compared to other 
substances (Been et al., 2015). Also, the purity of street 
products fluctuates unpredictably over time and in different 
locations. Furthermore, translating the total consumed 
amounts into the corresponding number of average doses is 
complicated, as drugs can be taken by different routes and in 
amounts that vary widely, and purity levels fluctuate (Zuccato 
et al., 2008).
Efforts are being made to enhance wastewater monitoring 
approaches. For example, work has been undertaken 
on overcoming a major source of uncertainty related 
to estimating the number of people present in a sewer 
catchment at the time of sample collection. This involved 
using data from mobile devices to better estimate the 
dynamic population size for wastewater-based epidemiology 
(Thomas et al., 2017).
I New developments and the future
Wastewater-based epidemiology has established itself as 
an important tool for monitoring illicit drug use and future 
directions for wastewater research have been explored 
(EMCDDA, 2016b).
First, wastewater analysis has been proposed as a tool to 
address some of the challenges related to the dynamic new 
psychoactive substances (NPS) market. This includes the 
large number of individual NPS, the relatively low prevalence 
of use and the fact that many of the users are actually 
unaware of exactly which substances they are using. A new 
technique has been established to identify NPS that involves 
the collection and analysis of pooled urine from stand-alone 
portable urinals from nightclubs, city centres and music 
festivals, thereby providing timely data on exactly which NPS 
are currently in use at a particular location (Archer et al., 
2013a, 2013b, 2015; Causanilles et al., 2017b; Kinyua, et al., 
2016; Mardal et al., 2017; Reid et al., 2014;). The European 
project ‘NPS euronet’ aims to improve the capacity to identify 
and assess the NPS being used in Europe. The project applies 
innovative analytical chemical and epidemiological methods 
and a robust risk-assessment procedure to improve the 
identification of NPS, to assess risks, and to estimate the 
extent and patterns of use in specific groups (e.g. at music 
festivals) and among the general population (Bade et al., 
2017; González-Mariño et al., 2016).
Interactive: explore the data from the study, available on the EMCDDA website: 
emcdda.europa.eu/topics/pods/waste-water-analysis
I  Interactive element
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Second, in addition to estimating illicit drug use, wastewater-
based epidemiology has been successfully applied in recent 
years to providing detailed information on the use and misuse 
of alcohol (Boogaerts et al., 2016; Mastroianni et al., 2017; 
Rodríguez-Álvarez et al., 2015), tobacco (Senta et al., 2015; 
van Wel et al., 2016b) and medicines in a specific population 
(Baz-Lomba et al., 2016, 2017; Been et al., 2015; Krizman-
Matasic et al., 2018; Salvatore et al., 2016,). Furthermore, 
wastewater analysis can potentially provide information on 
health and illness indicators within a community (Kasprzyk-
Hordern et al., 2014; Thomaidis et al., 2016; Yang et al., 2015).
Third, the potential for wastewater-based epidemiology to be 
used as an outcome measurement tool, in particular in the 
evaluation of the effectiveness of interventions that target 
drug supply (e.g. law enforcement) or drug demand (e.g. 
public health campaigns) has not yet been fully explored. 
Close collaboration between the different stakeholders 
involved, including epidemiologists, wastewater experts and 
legal authorities, is highly recommended in order to start 
examining these potential wastewater-based epidemiology 
applications (EMCDDA, 2016b).
Fourth, by back-calculating the daily sewer loads of target 
residues, wastewater analysis can provide total consumption 
estimates, and specific efforts are now being directed 
towards finding the best procedures for estimating annual 
averages. In 2016 the EMCDDA presented for the first time 
illicit drug retail market size estimates in terms of quantity 
and value for the main substances used (EMCDDA and 
Europol, 2016c). It is envisaged that findings from wastewater 
analysis can help to further develop work in this area.
Finally, new methods such as enantiomeric profiling have 
been developed to determine if mass loads of drugs in 
wastewater originated from consumption or from the disposal 
of unused drugs or production waste. It is now important to 
assess the possible utility of wastewater analysis to report on 
drug supply dynamics, including synthetic drug production 
(Emke et al., 2014).
Wastewater analysis has demonstrated its potential as 
a useful complement to established monitoring tools in 
the drugs area. It has some clear advantages over other 
approaches as it is not subject to response and non-
response bias and can better identify the true spectrum of 
drugs being consumed, as users are often unaware of the 
actual mix of substances they take. This tool also has the 
potential to provide timely information in short timeframes 
on geographical and temporal trends. In order to check the 
quality and accuracy of data, further comparisons between 
wastewater analysis and data obtained through other 
indicators are needed. 
As a method, wastewater analysis has moved from being 
an experimental technique to being a new method in the 
epidemiological toolkit. Its rapid ability to detect new trends 
can help target public health programmes and policy 
initiatives at specific groups of people and the different drugs 
they are using.
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In order to estimate levels of drug use from wastewater, 
researchers attempt first to identify and quantify drug 
residues, and then to back-calculate the amount of the 
illicit drugs used by the population served by the sewage 
treatment plants (Castiglioni et al., 2014). This approach 
involves several steps (see figure). Initially, composite 
samples of untreated wastewater are collected from 
the sewers in a defined geographical area. The samples 
are then analysed to determine the concentrations of 
the target drug residues. Following this, the drug use is 
estimated through back-calculation by multiplying the 
concentration of each target drug residue (nanogram/
litre) with the corresponding flow of sewage (litre/day). 
A correction factor for each drug is taken into account as 
part of the calculation. In a last step, the result is divided by 
the population served by the wastewater treatment plant, 
which shows the amount of a substance consumed per 
day per 1 000 inhabitants. Population estimates can be 
calculated using different biological parameters, census 
data, number of house connections, or the design capacity, 
but the overall variability of different estimates is generally 
very high. 
Although primarily used to study trends in illicit drug 
consumption in the general population, wastewater analysis 
has also been applied to small communities, including 
workplaces, schools (Zuccato et al., 2017), music festivals, 
prisons (Nefau et al., 2017) and specific neighbourhoods 
(Hall et al., 2012).  
 
Using this method in small communities can involve ethical 
risks (Prichard et al., 2014), such as possible identification 
of a particular group within the community. 
 
In 2016 the SCORE group published ethical guidelines for 
wastewater-based epidemiology and related fields (Prichard 
et al., 2016).  The objective of these guidelines is to outline 
the main potential ethical risks for wastewater research and 
to propose strategies to mitigate those risks. Mitigating risks 
means reducing the likelihood of negative events and/or 
minimising the consequences of negative events.
Understanding the wastewater method, and addressing ethical issues  
 






2. Sample analysis to obtain the 
concentrations of the target residues
1. Sample collection
(composite 24-h samples)
6. Amount of substance as doses/day/1 000 inhabitants
5. Normalisation of the amount of substance
to a dened population (g or mg/day/1 000 inhabitants)
4. Amount of a substance consumed by the 
population served by the treatment plant 
3. Amount of target residues entering
the treatment plant (g/day)
Source: (Castiglioni et al., 2013a)
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